Mihael Hristos Polymeropoulos is President and CEO of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 1.87 Million shares of VNDA, which is worth approximately $9.17 Million. The most recent transaction as insider was on Mar 05, 2024, when has been sold 24,288 shares (Common Stock) at a price of $4.13 per share, resulting in proceeds of $100,309. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.87M
0% 3M change
26.73% 12M change
Total Value Held $9.17 Million

Mihael Hristos Polymeropoulos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2024
SELL
Open market or private sale
$100,309 $4.13 p/Share
24,288 Reduced 1.28%
1,871,730 Common Stock
Mar 04 2024
SELL
Open market or private sale
$130,948 $4.24 p/Share
30,884 Reduced 1.6%
1,896,018 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
450,000 Added 18.93%
1,926,902 Common Stock
Mar 03 2023
SELL
Open market or private sale
$140,862 $6.25 p/Share
22,538 Reduced 1.5%
1,476,902 Common Stock
Mar 02 2023
SELL
Open market or private sale
$139,713 $6.23 p/Share
22,426 Reduced 1.47%
1,499,440 Common Stock
Feb 16 2023
BUY
Grant, award, or other acquisition
-
115,000 Added 7.03%
1,521,866 Common Stock
Dec 06 2022
SELL
Open market or private sale
$511,932 $10.61 p/Share
48,250 Reduced 3.32%
1,406,866 Common Stock
Dec 06 2022
BUY
Exercise of conversion of derivative security
$235,138 $3.12 p/Share
75,365 Added 4.92%
1,455,116 Common Stock
Dec 05 2022
SELL
Open market or private sale
$506,042 $10.62 p/Share
47,650 Reduced 3.34%
1,379,751 Common Stock
Dec 05 2022
BUY
Exercise of conversion of derivative security
$232,861 $3.12 p/Share
74,635 Added 4.97%
1,427,401 Common Stock
Mar 02 2022
SELL
Open market or private sale
$329,906 $11.15 p/Share
29,588 Reduced 2.14%
1,352,766 Common Stock
Mar 01 2022
SELL
Open market or private sale
$84,015 $11.19 p/Share
7,508 Reduced 0.54%
1,382,354 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
115,000 Added 7.64%
1,389,862 Common Stock
Dec 01 2021
SELL
Open market or private sale
$739,200 $16.0 p/Share
46,200 Reduced 3.5%
1,274,862 Common Stock
Dec 01 2021
BUY
Exercise of conversion of derivative security
$349,779 $4.88 p/Share
71,676 Added 5.15%
1,321,062 Common Stock
Nov 30 2021
SELL
Open market or private sale
$824,500 $16.49 p/Share
50,000 Reduced 3.85%
1,249,386 Common Stock
Nov 30 2021
BUY
Exercise of conversion of derivative security
$382,221 $4.88 p/Share
78,324 Added 5.69%
1,299,386 Common Stock
Mar 08 2021
SELL
Open market or private sale
$3,150,000 $18.0 p/Share
175,000 Reduced 12.54%
1,221,062 Common Stock
Mar 02 2021
SELL
Open market or private sale
$278,878 $18.34 p/Share
15,206 Reduced 1.08%
1,396,062 Common Stock
Mar 01 2021
SELL
Open market or private sale
$137,988 $18.45 p/Share
7,479 Reduced 0.53%
1,411,268 Common Stock
Feb 24 2021
BUY
Grant, award, or other acquisition
-
115,000 Added 7.5%
1,418,747 Common Stock
Dec 15 2020
SELL
Open market or private sale
$508,950 $13.0 p/Share
39,150 Reduced 2.92%
1,303,747 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$408,301 $8.75 p/Share
46,663 Added 3.36%
1,342,897 Common Stock
Dec 14 2020
SELL
Open market or private sale
$673,336 $13.19 p/Share
51,049 Reduced 3.79%
1,296,234 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$538,300 $8.75 p/Share
61,520 Added 4.37%
1,347,283 Common Stock
MHP

Mihael Hristos Polymeropoulos

President and CEO
Washington, DC

Track Institutional and Insider Activities on VNDA

Follow Vanda Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

News

Receive news related to Vanda Pharmaceuticals Inc.

Track Activities on VNDA